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Abstract The aim of this study was to evaluate the ef-
fects of photobiomodulation (PBM) on cancellous bone
in rat models of ovariectomized induced osteoporosis
(OVX-D) and glucocorticoid-induced osteoporosis
(GIOP). The experiment comprised of nine groups. A
group of healthy rats was used for baseline evaluations.
The OVX-D rats were further divided into groups as fol-
lows: control rats with osteoporosis, OVX-D rats that
received alendronate (1 mg/kg 60 days), OVX-D rats
treated with pulsed wave laser (890 nm, 80 Hz, 900 s,
0.0061 W/cm2, 5.5 J/cm2, three times a week, 60 days),
and OVX-D rats treated with alendronate + pulsed laser.
Dexamethasone was administered to the remaining rats
that were split into four groups: control, alendronate-
treated rats, laser-treated rats, and GIOP rats treated with
alendronate + laser. T12, L1, L2, and L3 vertebrae were
subjected to laser. Results of the current study demon-
strated that OVX-D and GIOP significantly decreased
some stereological parameters, and type 1 collagen gene
expression compared to the healthy group. There was a
significant increase in osteoclast number in both OVX-D
and glucocorticoid administration compared to the
healthy group. However, the detrimental effect of the
OVX-D procedure on bone was more serious than gluco-
corticoid administration. Results showed that laser alone
had a detrimental effect on trabecular bone volume, and
cortical bone volume in groups GIOP and OVX-D com-
pared to those in the healthy group. Alendronate signifi-
cantly improved total vertebral bone volume, trabecular
bone volume, and cortical bone volume, in GIOP and
OVX-D groups compared to the laser-treated groups.
Furthermore, the alendronate + laser in OVX-D rats and
GIOP rats produced significantly increased osteoblast
number and type 1 collagen gene expression and caused
a significant decrease in osteoclast number compared to
the controls.
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Abbreviations
OP Osteoporosis
GC Glucocorticoid
GIOP Glucocorticoid (GC)-induced OP
ECM Extracellular matrix
TGF-β Transforming growth factor beta
IGF-I Insulin-like growth factor-I
BMPs Bone morphogenetic proteins
rhPTH Recombinant human parathyroid hormone
PBM Photobiomodulation
PW Pulse wave
ALP Alkaline phosphatase
LED Light-emitting diode
RANKL Receptor activator of nuclear factor kappa-B
ligand
CW Continuous wave
OPG Osteoprotegerin
GaAlAs Gallium aluminum arsenide
OVX-D Ovariectomized induced OP
RT-PCR Real-time polymerase chain reaction
H Healthy
H&E Hematoxylin and eosin
ANOVA One-way analysis of variance
BMD Bone mineral density
DXA Dual-energy X-ray absorptiometry
GTP Guanosine triphosphate
PPARγ Peroxisome proliferator-activated receptor-γ
RUNX Runt-related transcription factor
Introduction
Bone tissue formation, maintenance, and repair depend on
finely tuned interaction of osteoclasts and osteoblasts.
Bone tissue is in a constant process of remodeling that
involves regeneration of its matrix; osteoblasts have a role
in new bone matrix deposits, while osteoclasts are in-
volved in degrading the old matrices. In a post-
menopausal skeleton, regenerative bone formation in the
arm ultimately declines, the process is known as primary
osteoporosis (OP) [1]. Glucocorticoid (GC)-induced OP
(GIOP) is the most common cause of secondary OP [2].
OP is a skeletal disorder distinguished by low bone mass
and micro-architectural deterioration of the bone tissue
that makes bones vulnerable and susceptible to fracture
[3]. Estimates show that among adults aged 50 years
and over in the USA (2010), 10.3% or 10.2 million peo-
ple suffered from OP in some region of the body such as
in the femoral neck or the lumbar spine [4]. OP can lead
to fracture even in cases of mild trauma, so it is very
important to maintain and treat patients with osteoporosis
in order to prevent fracture [5]. Osteoporotic fracture has
become a common condition but no satisfactory treatment
has been developed to date [6].
There are many cytokines and growth factors that gov-
ern bone cell activity during normal bone remodeling. The
extracellular matrix (ECM) releases substances such as
transforming growth factor beta (TGF-β) and insulin-
like growth factor-I (IGF-I) during bone resorption.
These factors recruit and activate osteoblasts to begin col-
lagen synthesis. Collagen type 1 is involved in skeletal
development and has a regulatory effect on bone cells
[7]. The process of osteoblast maturation is affected by
activity of various endocrine, paracrine, and autocrine
processes. These factors include a number of bone mor-
phogenetic proteins (BMPs) and IGF-I. The recombinant
human BMP-2 is a medical administration used to facili-
tate spinal fusion and is approved for OP therapy [8].
Prevention of OP and its complications is an essential so-
cioeconomic priority [9].
Drug agents for the treatment of OP are defined as either
antiresorptive (catabolic) or anabolic. Antiresorptive agents
such as bisphosphonate work by reducing osteoclast activity
and thus declining bone resorption. Teriparatide (recombinant
human parathyroid hormone (rPTH)1–34) is the only anabolic
agent currently available in the USA. PTH stimulates osteo-
blast function and bone formation of vertebral fracture [10].
Treatment with anabolic agents such as photobiomodulation
(PBM) is a strong stimulant for bone turnover and seems to be
a superior treatment compared with alendronate [11]. Some
investigations have demonstrated that laser irradiation had a
positive effect on osteoblasts in vitro. Ueda and Shimizu re-
ported that pulsed wave (PW) laser significantly stimulated
cellular proliferation, bone nodule formation, alkaline phos-
phatase (ALP) activity, and ALP gene expression, compared
with a non-irradiation group [12, 13]. Sohn et al. report on an
investigation on the impact of 635-nm irradiation dose from a
light-emitting diode (LED) on osteoclastogenesis in vitro. It
was reported that LED irradiation significantly inhibited re-
ceptor activator of nuclear factor kappa-B ligand (RANKL)-
mediated osteoclast differentiation from bone marrow-derived
macrophages. Sohn et al. present LED irradiation/laser as an
alternative, conservative approach to OP management [14].
Kiyosaki et al. reported the effects of continuous wave (CW)
laser on osteoblasts via insulin-like growth factor I (IGF-I)
signal transduction. The report suggests that laser escalates
in vitro mineralization by increasing IGF-I and BMP produc-
tion [15]. Xu et al. reported on the effect of laser (650 nm,
2 mW, 2.28 J/cm2, 6000 Hz) on messenger RNA (mRNA)
expression of RANKL and osteoprotegerin (OPG) in rat
calvarial cells. Xu et al. suggested that laser may have pro-
moted osteoblast proliferation and differentiation directly, and
indirectly inhibited of osteoclast differentiation by downregu-
lating the RANKL:OPG mRNA ratio in osteoblasts. Thus,
other research has shown that laser was beneficial for treating
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bone diseases such as OP [16]. In vivo studies have suggested
that both CW laser (632.8 nm, 10 mW, 382.2 J/cm2) and laser
(890 nm, 80 Hz, 0.972 J/cm2) improved biomechanical prop-
erties of tibia and vertebra compared to healthy bones in rats
[17–19]. Consistent with other reports, it has been confirmed
that laser (830-nm gallium aluminum arsenide (GaAlAs) laser
diode, 5 and 15 J/cm2) not only made changes in thickness of
the epiphyseal cartilage but also increased the number of the
chondrocytes [20].
However, research has some controversy over the ben-
efits of PBM for treatment of OP. Several studies have
reported a positive effect of PBM on ovariectomized in-
duced OP (OVX-D) rats, and orthodontic tooth movement
on post-menopausal women [21–24], whereas others have
reported no improvement in OVX-D and GIOP OP
models subjected to PBM [25–30]. To the best of our
knowledge, no study has yet examined the effects of laser
on gene expression and stereological analyses of histolog-
ical parameters in the vertebrae of OVX-D and GIOP rats.
Paraclinical information such as bone mineral density
(BMD), biochemical markers, histological parameters,
and gene expression findings can assist clinicians in de-
termining treatment for patients with OP [31]. The aim of
this study was to assess the effects of PBM on trabecular
bone in two rat models of OP. A stereological analysis of
histological parameters was done to make determinations
for total volume of vertebral bone, cortical bone volume,
trabecular bone volume, and total bone marrow volume
and by evaluating numbers of osteocyte, osteoblast, and
osteoclast. TGF-β, IGF-I, BMP-2, and type 1 collagen
gene expressions were measured using the real-time poly-
merase chain reaction (RT-PCR) method.
Materials and methods
Animals and study design
Fifty-four adult male and female Wistar rats, aged
18 weeks, were housed in standard rat cages in a 12-h
light/dark environment. Rats received water ad libitum.
The procedure was approved by the Medical Ethics
Committee of Shahid Beheshti University of Medical
Sciences, Tehran, Iran (protocol no. 1391-1-115-1092).
Rat body weight was measured weekly, and volumes of
drug application were calculated according to the most
recent body weight.
In this study, second and third vertebrae (L2 and L3) of
both OVX-D and GIOP rats received pulsed laser and
alendronate. L2 and L3 subsequently underwent a stereolog-
ical analysis of histological parameters and RT PCR gene
expression evaluation methods, respectively. The healthy (H)
group (group 5) comprised six normal rats used as the
baseline.
Sampling of OVX-D and GIOP groups
Fourty-eight rats were randomly divided into eight groups
(six rats per group) and treated as follows: there were four
groups of OVX-D rats and four groups of dexamethasone.
OVX was made on rats under sterile conditions via two
paravertebral skin incisions while rats were under general
anesthesia. Uterine tubes were ligated, and incisions were
closed after ovary removal. Rats received antibiotic ther-
apy with ceftriaxone (50 mg/kg) immediately before and
24 and 48 h after surgery [26]. All animals were kept in
cages for 14 weeks after surgery to allow development of
OP [26]. At the end of this period, rats were subjected to
the following treatments: group 1 (OC) comprised control
rats with OP, group 2 (OA) were OVX-D rats treated
subcutaneously with 1 mg/kg alendronate (Alborz Darou
Co., Tehran, Iran), group 3 (OL) consisted of OVX-D rats
that received laser three times weekly (Table 1), and
group 4 (OAL) were OVX-D rats treated with laser and
concomitant administration of alendronate (1 mg/kg). The
remaining rats received a daily intramuscular (i.m.) dose
of dexamethasone (1 mg/kg; Alborz Darou Co., Tehran,
Iran), administered 6 days per week for 5 weeks [26].
After 5 weeks, dexamethasone-treated rats were
subdivided into four groups: group 6 (control) consisted
of OP rats treated with i.m. injection of vehicle (distilled
water (DC)), group 7 (DA) or GIOP rats received
alendronate, group 8 (DL) consisted of GIOP rats treated
with laser (Table 1), and group 9 (DAL) was made up of
GIOP rats treated with laser and alendronate.
Laser and alendronate administration
Hashmi et al., in their review article, reported that PW
laser may be superior to CW light [32]. We observed the
beneficial effects of the current PW laser protocol in pre-
vious studies [18, 19]. In these studies, PW laser had a
remarkable effect on bone tissue at lower energy density
compared to that of CW laser. A gallium–arsenide (Ga-
As) laser (Mustang 2000; Technical Co., Moscow, Russia)
was used. All the laser radiation information were calcu-
lated and measured and shown in Table 2. Below, power
density calculation was reported. T12, L1, L2, and L3
vertebrae were subjected to laser, three times per week
for 2 months. The probe was fixed vertically with a por-
table holder at a distance of 0.5 cm above the skin (ver-
tebras). Subcutaneous injections of alendronate at a dose
of 1 mg/kg (Alborz Darou Co., Tehran, Iran) [26] were
performed daily for 30 days.
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Light source and method of power density determination
Power density ¼ energy density=duration of exposure
for each point
Power density ¼ 5:5=900
Power density ¼ 0:0061 W=cm2
In the laser-treated groups, T12, L1, L2, and L3 vertebras
were radiated with the laser probe that was held vertically to
the bone at the distance of less than 10 mm for 2 months.
During PW laser, animals were sedated by administration of
1/2 of the anesthetic drug dose. Rats received daily 30 mg/kg
alendronate for 30 days. At 2 months, after the beginning of
the treatment, all rats were euthanized by administration of an
overdose of anesthesia. The L2 and L3 vertebrae were extract-
ed carefully. L2 vertebral body used for histological examina-
tion and the L3 were frozen at −80 °C for RT-PCR gene
expression analysis.
Histological and stereological examinations
The bones were fixed in formalin saline and decalcified in
EDTA for 56 days. Primary volume V (primary) of vertebrae
was measured using the immersion method [25]. Then, verte-
brae were embedded in paraffin blocks and cut vertically into
5- and 25-μm-thick sections with a microtome. Slides were
stained using hematoxylin and eosin (H&E) dye for micro-
scopic descriptive analysis of each group. All measurements
were taken using a magnifying objective (×4, ×40).
Stereological study
Measurement of bone volumes
Live images of each section of vertebra were evaluated using a
projecting microscope. Following this procedure, eight to ten
sections were obtained and analyzed for each vertebra.
Volumes (V) were calculated using the Cavalieri method.
Table 2 Primers of the selected
genes for quantitative real-time
PCR
Gene Gene ID Primer sequences
TGF-beta1 NM_021578.2 Forward 5′ TAGCAACAATTCCTGGCGTTAC
Reverse 5′ CCTGTATTCCGTCTCCTTGGTTC
IGF-I NM_001082478.1 Forward 5′ GGAACATAAGGCACGCTGAAC
Reverse 5′TGAGGAAGCAGGTAGATGGTGA
BMP-2 NM_017178.1 Forward 5′ AGAAGCCAGGTGTCTCCAAGA
Reverse 5′ CCACATCACTGAAGTCCACATACA
Type1 collagen NM_053304.1 Forward 5′ GGAGCAGCAAGAGCAAGGAG
Reverse 5′ ACAGCAGGCGTAGGAAGGTC
Table 1 Specifications of the
laser used Parameters Dose and unit
Peak power output at surface of probe and distance of 0.5 cm 69 and 59.5 W
Average power 0.001 mW
Power density 0.001 W/cm2
Wavelength 890 nm
Pulse frequency 80 Hz
Spot shape and size of laser beam at the source Oval, 0.05 cm2
Spot shape and size of laser beam at distance of 0.5 cm Oval, 0.14 cm2
Pulsed duration 180 ns
Duration of exposure for each point 900 s
Energy densities at the surface of probe and at distance of 0.5 17.8 and 5.5 J/cm2
Divergence angle: horizontal × vertical angle 25 × 10°
The frequency of treatment Three times per week
Number of shootings per session 4
The cumulative dose (ED) given in each session 4 × 5.5 = 22 J/cm2
The cumulative dose (ED) given totally (23 sessions) 23 × 22 = 506 J/cm2
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Stereological software was used for grid points superimposed
on the images. The total vertebral volume of L2 was estimated
by the following formula:
V boneð Þ ¼ Σp a=p t
whereΣp is the total of points hitting a vertebral bone section,
a/p is the area associated with each point, and t is the distance
between the sampled sections [25].
Estimation of number of bone cells
The dissector method was used to estimate numerical density
and total number of bone cells. Specimens were evaluated at
×40 magnification with high numerical aperture. The captured
images were sent to the image analysis computer. The focus
plane was set at the surface of each specimen. Then, a set of
three unbiased measurement frames was superimposed on the
live image. At the same time, the microcator measuring the
optical distance through the specimen in the z axis was zeroed.
By gently moving the focus down through the specimen, an
approximately 0.5-mm-thin focal plane made objects come
into focus and then disappear. Bone cells that fell in the per-
mitted area of the measurement frame were counted as they
came into focus until the microcator showed that the focal
plane had traveled 10 μm through the specimen. Numerical
density of cells was obtained by
Nv ¼ ΣQ−= h a=ƒ Σpð Þ

 t=BAð Þ
whereΣQ− is the number of cells counted in all the dissectors,
h is the height of the optical dissector, a/ƒ is the area of the
counting frame,Σp is the total number of counted frames, BA
is the microtome block advance to cut the block (25 μm), and t
is the mean of the final section thickness (20 μm). The fol-
lowing formula was used to estimate the total number of bone
cells: N (bone cell) = Nv × V (final) [25].
RNA extraction
Frozen bones crushed by Chinese Haven were homogenized
in TRIzol (Invitrogen, USA) using a tissue laser instrument
(Qiagen, GmbH). The total RNAwas purified. Of the chloro-
form (Merck, Germany), 200 μL was added to the resultant
TRIzol mixture; samples were then shaken intensely and in-
cubated at room temperature for 5 min. Samples were centri-
fuged at 10,000 rpm for 20 min at 4 °C. The separated, color-
less aqueous layer was mixed with 0.5 mL of isopropanol.
Samples were centrifuged again at 10,000×g or 10,000 rpm
for 20 min at 4 °C. The pellet was suspended in 1 mL ethanol
and centrifuged at 12,000 rpm for 20 min at 4 °C. The resul-
tant pellet was dried for 10 min at room temperature.
Nuclease-free deionized water (50 μL) was added, and the
RNA concentration was estimated by UV spectrophotometry
at a 260-nm wavelength. Purity was assessed by ratios of
A260/A280 and A260/A230.
Prior to reverse transcription, each sample was treated with
RNase-free DNase I (TaKaRa Bio Inc., Japan) to remove any
contaminating DNA. For RT-PCR, 1 μg total RNA was re-
versely transcribed to complementary DNA (cDNA) with
oligo(dT) and random hexamer primers using 1 u/mL M-
MLV reverse transcriptase (Invitrogen, CA, USA) at 95 °C
for 15 min and 42 °C for 45 min [25].
Real-time PCR
Expression of the candidate gene development was analyzed
using quantitative RT-PCR with the SYBR®Green Real-time
PCR Master Mix (TaKaRa Bio, Inc.). Table 2 shows the oli-
gonucleotide primers.
For each sample, three replicates were produced for each
target gene in a final volume of 20 μL that contained 10 μL of
2× SYBR®Green PCRMaster Mix, 1 μL cDNA, 2 μL of the
forward and reverse primers, and 7 μL of water.
Thermocycling conditions were as follows: an initial denatur-
ation at 95 °C for 2 min, followed by 35–40 cycles of 92 °C
for 15 s, 60 °C annealing for 30 s, and a 72 °C extension for
45 s. Specificity of the PCR amplification procedure was
checked with a melting curve. Quantification of the relative
changes in gene expression was performed using the 2−ΔΔCt
method [25]. The mRNA level of candidate genes was nor-
malized to the signal for 18S ribosomal RNA (rRNA).
For each sample, expression was performed in a final vol-
ume of 20μL that contained 10 μL of 2× SYBR®Green PCR
Master Mix, 1 μL cDNA, 2 μL of the forward and reverse
primers, and 7 μL of water. Thermocycling conditions were as
follows: an initial denaturation at 95 °C for 2 min, followed by
35–40 cycles of 92 °C for 15 s, 60 °C annealing for 30 s, and a
72 °C extension for 45 s. Melting curve was used to check
specificity for each PCR amplification procedure.
Quantification of the relative changes in gene expression
was performed using the 2−ΔΔCt method [25]. The mRNA
levels of candidate genes were normalized to the signal for
18S rRNA [25].
Statistical analysis
All data were expressed as mean ± standard errors of mean
(SEMs). Normal distribution of data was analyzed using the
Shapiro test. Parametric and non-parametric statistical
methods were used. One-way analysis of variance
(ANOVA) was used to compare changes among groups with
normal distribution of data, and the least significant difference
(LSD) test was used to identify differences. A p value of <0.05
was considered statistically significant. Non-parametric
methods were used for statistical analysis of the other groups.
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These data were analyzed using the Kruskal-Wallis and
Mann-Whitney U tests. Difference was significant if
p < 0.005 for analyses between groups 1 and 9. Difference
was also regarded as significant if p ≤ 0.01 for analyses be-
tween groups 1 and 5 and groups 5 and 9.
Results
General observations
Evaluations for blood glucose level and body weight of rats in
the studied groups were reported in our previous study [21].
L2 weight in the studied groups are shown in Fig. 1.
According to the LSD test, the vertebral weight of the DL
group significantly decreased compared to DA (p = 0.000),
DC (p = 0.001), DAL, and healthy (both p = 0.003) groups.
OVX significantly decreased the vertebral weight of OA
(LSD test, p = 0.012), OL (p = 0.022), and OC (p = 0.07)
groups in comparison to the healthy group. All results are
reported in Fig. 1.
Stereological analyses
Light micrographs of studied groups are shown in Fig. 2.
Results of stereological analyses are shown in Figs. 3, 4, 5,
6, 7, 8, and 9.
In terms of total vertebral bone volume (mm2), results of
the LSD test demonstrated a significant decrease in total ver-
tebral bone volume in the DL group compared to the DA
(p = 0.000), DC and H (both p = 0.001), and DAL
(p = 0.003) groups. OVX significantly decreased total verte-
bral bone volume of OA (p = 0.012), OL (p = 0.22), and OC
(p = 0.027) groups compared to the healthy group. All results
are shown in Fig. 3.
Results showed a significant decrease in trabecular bone
volume (mm2) in DC (LSD test, p = 0.001), DL (p = 0.002),
and DAL (p = 0.003) compared to the healthy group. Results
showed a significant decrease in trabecular bone volume of
DL compared to DA (p = 0.000), DC (p = 0.002), and DAL
(p = 0.003). There was a significant decrease in trabecular
bone volume of OC, OA, OL, and OAL (all p = 0.000) com-
pared to H group. All results are shown in Fig. 4.
Results showed a significant increase in cortical bone vol-
ume (mm2) in DA (LSD test p = 0.000) and DC (p = 0.001),
DAL (p = 0.002), and healthy (p = 0.027) groups compared to
the DL group. A significant increase was observed in cortical
bone volume in the DA group compared to H and DC groups
(p = 0.000 and 0.007, respectively). All results are shown in
Fig. 5.
Results for total bone marrow volume (mm2) in the DL
group showed significant decrease in total bone marrow vol-
ume compared to the DA (LSD test, p = 0.000), DAL
(p = 0.002), and H (p = 0.003) groups. Significant decrease
Fig. 1 Mean ± SEM of L2 vertebral weight (mg) of the studied groups
compared by the LSD test; *p < 0.05, **p < 0.01, ***p < 0.001.
Ovariectomized (OVX-D) control rats (OC), OVX-D rats treated with
alendronate (OA), OVX-D rats treated with laser (OL), OVX-D rats
treated with laser and alendronate (OAL), healthy rats (H),
dexamethasone-treated control rats (DC), dexamethasone-treated rats
that received alendronate (DA), dexamethasone-treated rats that
received laser (DL), and dexamethasone-treated rats that received
alendronate and laser (DAL). According to the LSD test, the vertebral
weight of the DL group significantly decreased compared to DA, DC,
DAL, and healthy groups. OVX significantly decreased the vertebral
weight of OA, OL, and OC groups in comparison to healthy group
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was observed in total bonemarrow volume of OA (p = 0.012),
OL (p = 0.022), and OC (p = 0.027) groups compared to
healthy group. All results are shown in Fig. 6.
ANOVA test showed no significant differences in osteo-
cyte numbers (106) of dexamethasone-treated groups.
According to the LSD test, significant decreases were detected
in osteocyte numbers in the OL and OC (both groups,
p = 0.000), OA (p = 0.005), and OAL (p = 0.006) groups
compared to H group. All results are shown in Fig. 7.
According to the Mann-Whitney test, there was non-
significant difference in osteoblast number (106) in the
dexamethasone-treated rats. According to the LSD test, sig-
nificant decrease was recognized in osteoblast number of OC
and OL groups (both p = 0.000) and OA (p = 0.013) group
Fig. 2 Light micrographs of studied groups (H&E). BM bone marrow, TR trabecula, oc osteocyte, ob osteoblast
Fig. 3 Mean ± SEM of the total
vertebral volume (mm2) of the
studied. Groups compared by
LSD test; *p < 0.05, **p < 0.01,
***p < 0.001. LSD test showed a
significant decrease in total
vertebral bone volume in the DL
group compared to DA, DC and
H, and DAL groups. OVX
significantly decreased total
vertebral volume of OA, OL, and
OC groups
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compared to the healthy group. Significant decrease in osteo-
blast number of OL compared to OAL (p = 0.005) and OA
(p = 0.02) as well as significant increase in osteoblast number
of OA andOAL (both groups, p = 0.003) compared to OC. All
results are shown in Fig. 8.
According to the LSD test, significant increase was
discovered in osteoclast number in the DC (106) group
compared to healthy, DAL, and DA groups (all
p = 0.000). Significant increase existed in osteoclast num-
ber in the DL group in comparison to DAL and DA
groups (p = 0.004 and p = 0.005, respectively).
According to the LSD test, significant increases were de-
termined in osteoclast number in the OC group compared
to OA (p = 0.002), OAL (p = 0.004), H (p = 0.006), and
OL (p = 0.015) groups. All results are shown in Fig. 9.
Real-time PCR analysis
The results of RT-PCR analysis are shown in Figs. 10, 11, 12,
and 13.
According to the ANOVA test, there was non-significant
difference in TGF-β1 between the studied groups. All results
are demonstrated in Fig. 10.
According to the Mann-Whitney test, there was significant
decrease in IGF-1 of DL group compared to DC group
(p = 0.004). Results showed a significant decrease in IGF-1
of OL group compared to OC group (p = 0.005). All results
are shown in Fig. 11.
According to the Mann-Whitney test, there was signif-
icant decrease in BMP-2 of DC group compared to DAL
group (p = 0.009). Significant decrease was determined in
Fig. 4 Mean ± SEM of the
trabecular bone volume (mm2) of
the studied groups compared by
LSD test; **p < 0.01,
***p < 0.001. There were
significant differences in
trabecular bone volume (mm2) in
DC, DL, and DAL compared to
healthy group. We found
significant decrease in trabecular
bone volume of DL compared to
DA, DC, and DAL. Significant
decrease existed in trabecular
bone volume of OC, OA, OA,
and OAL compared to H group
Fig. 5 Mean ± SEM of the
cortical bone volume (mm2) of
the studied groups compared by
LSD test; *p < 0.05, **p < 0.01,
***p < 0.001. There were
significant increases that existed
in cortical bone volume (mm2) in
DA and DC, DAL, and healthy
groups compared to the DL
group. We observed a significant
increase in cortical bone volume
in the DA group compared to the
DC and H groups
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IGF-1 of OL group compared to H and OAL groups (both
p = 0.004). All results are shown in Fig. 12. In terms of
type 1 collagen, the DL group showed significant increase
compared to H and DAL groups (Mann-Whitney test
p = 0.000 and p = 0.004, respectively). DA group indi-
cated significant increase in type 1 collagen compared to
H and DAL groups (Mann-Whitney test p = 0.001 and
p = 0.000, respectively). And the DC group also showed
significant enhancement in type 1 collagen compared to H
and DAL groups (Mann-Whitney test p = 0.004 and
p = 0.000, respectively). OL group showed significant
increase in type 1 collagen compared to OAL and H
groups (Mann-Whitney test p = 0.004 and p = 0.008, re-
spectively). OA group indicated significant increase in
type 1 collagen compared to H group (Mann-Whitney test
p = 0.008). OC group showed significant decrease in type
1 collagen compared to H group (Mann-Whitney test
p = 0.002). All results are illustrated in Fig. 13.
Fig. 6 Mean ± SEM of the bone
marrow volume (mm2) of the
studied groups compared by LSD
test; *p < 0.05, **p < 0.01,
***p < 0.001. DL group showed
the significant decrease in total
bone marrow volume compared
to the DA, DAL, and H groups.
We observed significant decrease
in total bone marrow volume of
OA and OC groups compared to
healthy group. All results are
shown in Fig. 5
Fig. 7 Mean ± SEM of the
osteocyte numbers (106) of the
studied groups compared by
ANOVA test; *p < 0.05,
**p < 0.01, ***p < 0.001.
ANOVA test showed no
significant differences in
osteocyte numbers (106) of
dexamethasone-treated groups.
According to the LSD test, there
were significant differences in
osteocyte numbers in the OL and
OC, OA, and OAL groups
compared to H group
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Discussion
Results of the current study demonstrate that OVX-D signif-
icantly decreased evaluations of vertebral weight, total ver-
tebral bone volume, trabecular bone volume, total bone mar-
row volume, osteocyte number, osteoblast number, and type
1 collagen gene expression in comparison to test results in
the healthy group. Results for GIOP showed a significant
decline in trabecular bone volume compared to the healthy
group. Results also showed a significant increase of osteo-
clast number of groups of OVX-D and glucocorticoid
adminis t ra t ion compared to the heal thy group.
Additionally, the detrimental effect of the OVX-D procedure
on bone was more serious than that of glucocorticoid admin-
istration. Furthermore, results indicated decreased trabecular
bone volume in both tested models. Rapid bone loss has
been reported during the first few years after menopause,
especially in the trabecular compartment that results in tra-
becular perforation followed by entire loss of trabeculae
[33]. Nordin et al. suggested that the main determinant of
age-related bone loss in women was increased bone resorp-
tion and that further trabecular bone loss associated with
Fig. 8 Mean ± SEMof the osteoblast numbers (106) of the studied groups;
**p < 0.01, ***p < 0.001. Mann-Whitney test showed that there were no
significant differences in osteoblast numbers (106) in the dexamethasone-
treated rats. According to the LSD test, we observed significant decreases
in osteoblast numbers of OC and OL groups, and OA group compared to
healthy group. We observed significant decrease in osteoblast numbers of
OL compared to OAL and OA .We also found significant increase in
osteoblast numbers of OA and OAL compared to OC
Fig. 9 Mean ± SEM of the
osteoclast numbers (106) of the
studied groups compared by LSD
test; *p < 0.05, **p < 0.01,
***p < 0.001. There were
significant increases in osteoclast
numbers in the DC (106) group
compared to healthy, DAL, and
DA groups. Significant increase
existed in osteoclast numbers in
the DL group compared to DAL
and DA groups. According to the
LSD test, we observed significant
increases in osteoclast numbers in
the OC group compared to OA,
OAL, H, and OL groups
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vertebral compression was mainly attributable to a further
increase in resorption [34]. In post-menopausal osteoporotic
women, there is increased bone turnover [35]; the similarity
to OP in OVX-D rats is associated with increased turnover
due to increased resorption that exceeds bone formation
[36]. This is closely associated to the direct effect of estro-
gen on calcium absorption that has a direct influence on
bone turnover [37]. Moreover, a significant decrease of total
vertebral bone volume and trabecular bone volume was de-
termined in the OVX-D group, and a decrease of trabecular
bone volume in GIOP group compared to that in healthy
rats. Approximately 80% of the total skeleton are composed
of cortical bone, and the rest is composed of trabecular bone.
Certain regions of the skeleton are rich in trabecular bone.
These areas include vertebrae, femoral neck, and distal radi-
us [38]. There is rapid loss of trabecular bone after meno-
pause [39]. It has been reported that GC changes the trabec-
ular property of bone. Reports have also shown increased
trabecular surface remodeling and trabecular bone structure
deterioration [39, 40].
Fig. 10 Mean ± SEM of the
TGF-β of the studied groups
compared by ANOVA test. There
were not significant differences in
TGF-β between studied groups
Fig. 11 Mean ± SEM of the IGF-
1 of the studied groups compared
byMann-Whitney test; *p < 0.05,
**p < 0.01, ***p < 0.001. There
were significant decrease in IGF-
1 of DL group compared to DC
group. We also found significant
decrease in IGF-1 of OL group
compared to OC group
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Micro-architecture refers to the microscopic morpholo-
gy and organization of trabecular and cortical bone. It is
characterized using bone histomorphometry and micro-CT
(μ-CT) scanning to obtain two-dimensional/three-dimen-
sional measurement of the architecture at various resolu-
tions. Estimation of the three-dimensional properties of
the architecture from a two-dimensional histological sec-
tion is known as stereology [41]. Stereology is typically
used to determine bone micro-architecture by quantifying
cortical porosity, cortical thickness, trabecular number,
trabecular thickness, and trabecular connectivity; it has
been illustrated that at the onset of post-menopausal OP,
trabecular weakening, deeper resorption cavities, micro-
fracture, and loss of trabecular connectivity occur [42].
Until recently, it was believed that bone loss occurred at
the same extent throughout the trabecular architecture and
that such loss was irreversible [7]. However, recent imag-
ing generated by high-resolution in vivo μ-CT scanners
Fig. 12 Mean ± SEM of the
BMP-2 of the studied groups
compared by Mann-Whitney test;
**p < 0.01. According to the
Mann-Whitney test, there was
significant decrease in BMP-2 of
DC group compared to DAL
group. We found significant
decrease in IGF-1 of OL group
compared to H and OAL groups
Fig. 13 Mean ± SEM of the type
1 collagen of the studied groups
compared by Mann-Whitney test;
**p < 0.01, ***p < 0.001. In
terms of type 1 collagen, DL
group showed significant increase
compared to H and DAL groups.
DA group showed significant
increase in type 1 collagen
compared to H and DAL groups
too. And also DC group showed
significant increase in type 1
collagen compared to H and DAL
groups too (Mann-Whitney test
p = 0.004 and p = 0.000,
respectively). In terms of type 1
collagen, OL group showed
significant increase compared to
OAL and H groups. OA group
showed significant increase in
type 1 collagen compared to H
group. OC group showed
significant decrease in type 1
collagen compared to H group
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has produced new findings that question this assumption.
Waarsing et al. report that following initial trabecular
thinning in OVX-D rats, the few remaining trabecular
subsequently recovered slowly and increased in thickness
[43, 44]. Stereological results showed that laser signifi-
cantly decreased total vertebral bone volume, trabecular
bone volume, cortical bone volume, and bone marrow
volume in glucocorticoid-treated rats compared to those
in the healthy group; laser also significantly decreased
total vertebral bone volume, bone marrow volume, osteo-
cyte number, and osteoblast number in OVX-D rats.
Bone is a complex tissue. Its fundamental function is to
resist mechanical injury and absorb pressure. Bone strength
depends on quantity of bone tissue and its quality, which is
outlined by the geometry and shape of the bone, the micro-
architecture of the trabecular bone morphology, cortical
thickness, and porosity; it is also characterized by intrinsic
properties of bony tissue such as turnover, mineral, and
collagen. These determinants of bone quality are interrelat-
ed, especially mineral and collagen, and analysis of their
specific roles in bone strength is difficult to identify. The
major complication of some bone diseases such as osteopo-
rosis, i.e., fracture, is due to weak bone strength. Therefore,
any treatment of OP relies on improving bone strength.
Bone strength is indirectly measured by BMD using dual-
energy X-ray absorptiometry (DXA). Since DXA-measured
BMD represents 60–70% of the variation in bone strength,
some important factors are not determined by DXA, in
terms of the effects of antiosteoporotic treatment and the
progression of OP. In addition to BMD, geometry and tra-
becular micro-architecture also need consideration. Thus,
evaluation of the intrinsic mechanical quality of bone
should provide a better understanding of the role of tissue
quality in determining bone strength [38, 45, 46].
Consistent with results of our recent study, it is reported
that laser significantly improved important biomechanical
parameters of the vertebrae in glucocorticoid-induced OP
and OVX-D tests compared to results of healthy and control
groups, respectively [21].
Osteoblast cells synthesize collagen during the initial phase
of bone formation when unmineralized bone (osteoid) is
made. The collagen molecules are assembled extracellularly
and immature ketomine and aldimine cross-links are formed;
these contribute to the formation of mature pyridinium or pyr-
role cross-links. Together, these cross-links result in fibril for-
mation that act as a scaffold for bone minerals and provide
strength [7, 46, 47]. The collagen in bone is primarily type I
collagen, but types III, IV, and VI are also present [48]. At the
onset of post-menopausal OP, diverse changes in the compo-
sitional properties of the collagen have been reported; a recent
study indicates that synthesis of type I collagen enhanced
during OP, while earlier studies reported reduced amounts of
type VI collagen and type III collagen [7, 49].
It was determined that evaluations of vertebral weight, total
vertebral bone volume, trabecular bone volume, cortical bone
volume, and total bone marrow volume of the DA group were
significantly higher in comparison to results from the DL
group and that number of osteoclasts in the DA group was
significantly lower than that of the DL group (p = 0.005). It
was also found that osteoblast number of the OA group was
significantly higher compared to the OL group.
Bisphosphonates are currently used as a first-line therapeu-
tic agent for OP. Bisphosphonates inhibit bone resorption by
selective adsorption to a mineral surface and subsequent inter-
nalization by bone-resorbing osteoclasts where they interfere
with various biochemical processes. Alendronate inhibits a
key enzyme, farnesyl pyrophosphate synthase, in the
mevalonate pathway that prevents biosynthesis of isoprenoid
compounds that are considered essential for post-translational
modification of small guanosine triphosphate (GTP)-binding
proteins. Both protein prenylation and function of these regu-
latory proteins are impaired, leading to osteoclast dysfunction
[48]. Results of the current study demonstrated that
alendronate alone was statistically more effective than laser
alone on the above-mentioned stereological parameters.
In the present study, the effects of laser irradiation were
examined on IGF-I and BMP-2, which are considered as the
most important factors in bone formation in healthy animals
[49]. There is evidence to show that expression of molecules
that modulate osteoblast activity may be altered during post-
menopausal osteoporosis. During physiologic bone resorp-
tion, growth factors such as IGF-I and TGF-β are released
from the extracellular matrix, which recruit and activate oste-
oblasts to begin collagen synthesis [7]. Osteogenic and
adipogenic processes are modulated by the BMP-2. This cy-
tokine regulates expression of the nuclear receptor peroxisome
proliferator-activated receptor-γ (PPARγ) and Runt-related
transcription factor 2 (RUNX2) [50]. Laser can promote bone
formation and inhibit bone resorption, thus facilitating bone
remodeling [12–15]. However, it was demonstrated that laser
significantly decreased IGF-I and BMP-2 in both tested
models of OP.
Interestingly, it was found that laser treated in both test
models of OP showed significant increase of type 1 collagen
gene expression compared to those in the healthy group.
Results for laser in OVX-D rats and GIOP rats in combination
showed significantly increased osteoblast number and type 1
collagen gene expression, and significantly decreased osteo-
clast number compared to control groups. These results (sig-
nificant increase of type 1 collagen gene expression) may be
in agreement with increasing biomechanical properties of the
osteoporotic vertebrae in the laser-treated rats as recently re-
ported in Bayat et al. [21]. Bayat et al. report on an evaluation
of the effects of laser on cancellous bone strength in OVX-D
and GIOP test model of OP. There were four OVX-D groups
and four dexamethasone-treated groups. Laser (890 nm,
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80 Hz, 5.5 J/cm2) was carried out on the spinal processes of
the vertebrae T12, L1, L2, and L3. Biomechanical test find-
ings indicate a positive influence of laser and alendronate
administration on increasing bending stiffness and maximum
force of the osteoporotic bones in comparison to the healthy
group. Furthermore, laser treatment of OVX-D rats signifi-
cantly escalated stress high load compared to OVX-D control
rats. Bayat et al. concluded that laser conserved cancellous
(trabecular) bone of vertebrae against the detrimental influ-
ence of OVX-D osteoporosis on bone strength in rats in com-
parison to the control.
These results demonstrate that laser alone had a detrimental
effect on many stereological parameters such as total vertebral
bone volume, trabecular bone volume, cortical bone volume,
and bone marrow volume in both glucocorticoid-treated rats
and OVX-D rats compared to those in the healthy group.
Furthermore, results showed that the combination of
alendronate and laser in OVX-D rats and GIOP rats signifi-
cantly increased osteoblast number and type 1 collagen gene
expression and significantly decreased osteoclast number
compared to that of the controls. The results of this study were
in agreement with result of other studies. Diniz et al. report on
evaluation on the effect of laser in combination with
alendronate sodium on osteopenic bone. Laser (GaAlAs;
830 nm, 50 mW, and 4 J/cm2) on the femoral neck and verte-
bral segments were performed. In the osteopenic +
alendronate sodium group, the trabecular bone volume in L2
was significantly higher than that in the controls. Notably, in
the combination between laser and alendronate sodium, the
trabecular bone volume in osteoporotic animals was signifi-
cantly higher in vertebrae L2 and T13 than osteoporotic bone
and was similar to that in the sham-operation group. Diniz
et al. demonstrated that treatment with laser together with
bisphosphonate therapy was the most effective on reversing
vertebral osteopenia due to the ovariectomy [28].
Mohsenifar et al. reported an investigation of the effect of
laser on the cortical bone of osteoporotic rat tibia in two test
models, GIOP rats and OVX-D rats. GIOP rats and OVX-D
rats treated with alendronate (1 mg/kg) and laser (890 nm,
80 Hz, 0.972 J/cm2). Rats were given alendronate for 30 days
and subjected to laser three times per week for 8 weeks. Tests
demonstrated a significant rise in cortical bone volume in all
study groups compared to healthy rats. Results showed signif-
icant reduction in trabecular bone volume in all study groups
compared to healthy rats. The control rats with OP showed
significantly increased osteoclast number. Alendronate signifi-
cantly decreased osteoclast number in osteoporotic rats. In the
laser + alendronate group, the same effect was observed on
osteoporotic bone [25]. Fridoni et al. report on the effects of
laser on cortical bone in OVX-D and GIOP test models of OP
in rats. The osteoporotic rats received alendronate for 30 days.
Laser (890 nm, 80 Hz, 0.972 J/cm2) was performed on the tibia
three times per week for 2 months. After 2 months, tibia were
extracted and submitted to a three-point bending test. Laser did
not enhance the biomechanical parameters of osteoporotic
bones compared to controls and healthy rats. Laser with
alendronate treatment significantly increased stress high load
in OVX-D rats compared to those in the healthy group [26].
The physical parameters used in PW laser such as wave-
length, power (peak power, average power, and power
density),pulse frequency, pulse duration (width), duration of
exposure, and energy density all impact the biological effects
of laser irradiation [32, 51]. PW laser at 5.5-J/cm2 energy
density and other delivery parameters used in the current study
failed to cause any beneficial effects in the histological and
gene expression parameters of osteoporotic bones. A probable
cause is the relatively lower energy density of laser employed
in this study. The applied dose was selected in accordance
with two studies that demonstrated increased bone density in
rats from an 890-nm infrared laser at 0.972 J/cm2 [19, 32].
Recently, Muniz Renno et al. studied the effects of PBM
(830 nm, 100 W/cm2, 120 J/cm2) on femurs of exercised os-
teoporotic rats. The exercise program and the laser radiation
were performed 48 h over an 8-week period. The exercise
program consisted of jumps. Femurs were submitted to a
physical and geometrical property evaluation, a biomechani-
cal test, and calcium and phosphorus evaluation. Muniz
Renno et al. concluded that exercised animals showed higher
bone strength and physical property values. However, the
PBM did not improve the biostimulatory effects of the exer-
cise on the osteoporotic rats [30].
It was concluded that PBM alone had a detrimental effect
on many stereological parameters of vertebral bone such as
total vertebral bone volume, trabecular bone volume, cortical
bone volume, and bonemarrow volume in both GIOP rats and
OVX-D rats compared the healthy group. Alendronate signif-
icantly improved many stereological parameters such as total
vertebral bone volume, trabecular bone volume, cortical bone
volume, and bone marrow volume in both GIOP rats and
OVX-D rats compared to those in laser groups. Furthermore,
the combination of alendronate and laser in OVX-D rats and
GIOP rats significantly increased osteoblast number and type
1 collagen gene expression. Since the PBM had osteogenic
effects, different laser parameters should be examined to ver-
ify whether an appropriate laser protocol alone or administra-
tion with a proper antiosteoporotic agent might reverse the
detrimental effects of OP. We suggest measuring Ca++ levels
on blood in further studies.
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